Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Recipient cytotoxic T lymphocyte antigen-4 +49 G/G genotype is associated with reduced incidence of hepatitis B virus recurrence after liver transplantation among Chinese patients.

Recipient cytotoxic T lymphocyte antigen-4 +49 G/G genotype is associated with reduced incidence of hepatitis B virus recurrence after liver transplantation among Chinese patients. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Recipient cytotoxic T lymphocyte antigen-4 +49 G/G genotype is associated with reduced incidence of hepatitis B virus recurrence after liver transplantation among Chinese patients. Abstract Text:

    zhijun jiangZhijun Jiang,xiaoning fengXiaoning Feng,wu zhangWu Zhang,feng gaoFeng Gao,qi lingQi Ling,lin zhouLin Zhou,haiyang xieHaiyang Xie,qixing chenQixing Chen,shusen zhengShusen Zheng,zhijun jiangZhijun Jiang,xiaoning fengXiaoning Feng,wu zhangWu Zhang,feng gaoFeng Gao,qi lingQi Ling,lin zhouLin Zhou,haiyang xieHaiyang Xie,qixing chenQixing Chen,shusen zhengShusen Zheng,zhijun jiangZhijun Jiang,xiaoning fengXiaoning Feng,wu zhangWu Zhang,feng gaoFeng Gao,qi lingQi Ling,lin zhouLin Zhou,haiyang xieHaiyang Xie,qixing chenQixing Chen,shusen zhengShusen Zheng,

    BACKGROUND: Single-nucleotide polymorphisms (SNP) of two-gene locus cytotoxic T lymphocyte antigen-4 (CTLA-4) +49 and CD86 +1057 were previously reported to influence the outcome of liver transplantation (LT) with respect to allograft acceptance. SNP at CTLA-4 +49 was also suggested to be associated with the individual difference in the clearance of hepatitis B virus (HBV). However, their influence on the incidence of post-LT HBV reinfection was not clear. With the increasing knowledge of costimulatory mechanisms on LT and host immune response, we designed this study to investigate the relationship between different alleles as well as genotypes at these two locations and HBV reinfection after LT. METHODS: Genomic DNA from 167 LT recipients with HBV-related diseases was genotyped for CTLA-4 +49 and CD86 +1057 genomic polymorphisms using a sequence-specific primer-polymerase chain reaction (PCR-SSP). HBV recurrence was diagnosed based on the serological and pathological finding of HBV DNA and HBsAg. RESULTS: The present study indicated that the recipients with CTLA-4 +49 GG genotype had a reduced risk (6.67%) of HBV recurrence compared with non-CTLA-4 +49 GG-carrying individuals (20.7%) (relative risk 3.098) (P=0.032). The allelic frequency of CTLA-4 +49 G was also significantly lower in patients with HBV recurrence, compared with that in patients without HBV recurrence (P=0.013, odds ratio 2.176, 95% confidence interval 1.170-4.046). However, no significant association was found between CD86 +1057 and HBV recurrence. CONCLUSION: Our result on CTLA-4 +49 A/G polymorphism indicated that the CTLA-4 +49 GG genotype was related to a reduced risk in the incidence of HBV recurrence.

    Recipient cytotoxic T lymphocyte antigen-4 +49 G/G genotype is associated with reduced incidence of hepatitis B virus recurrence after liver transplantation among Chinese patients. Publishing Authors By Initials

    z jiangZ Jiang,x fengX Feng,w zhangW Zhang,f gaoF Gao,q lingQ Ling,l zhouL Zhou,h xieH Xie,q chenQ Chen,s zhengS Zheng,z jiangZ Jiang,x fengX Feng,w zhangW Zhang,f gaoF Gao,q lingQ Ling,l zhouL Zhou,h xieH Xie,q chenQ Chen,s zhengS Zheng,z jiangZ Jiang,x fengX Feng,w zhangW Zhang,f gaoF Gao,q lingQ Ling,l zhouL Zhou,h xieH Xie,q chenQ Chen,s zhengS Zheng,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Recipient cytotoxic T lymphocyte antigen-4 +49 G/G genotype is associated with reduced incidence of hepatitis B virus recurrence after liver transplantation among Chinese patients. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Liver international : official journal of the Inte

    VOLUME: 27

    Page Numbers: 1202-8

    Journal Abbreviation: Liver Int.

    ISSN: 1478-3223

    DAY: 8

    MONTH: Nov

    YEAR: 2007

    Recipient cytotoxic T lymphocyte antigen-4 +49 G/G genotype is associated with reduced incidence of hepatitis B virus recurrence after liver transplantation among Chinese patients. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101160857

    Recipient cytotoxic T lymphocyte antigen-4 +49 G/G genotype is associated with reduced incidence of hepatitis B virus recurrence after liver transplantation among Chinese patients. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Recipient cytotoxic T lymphocyte antigen-4 +49 G/G genotype is associated with reduced incidence of hepatitis B virus recurrence after liver transplantation among Chinese patients. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Recipient cytotoxic T lymphocyte antigen-4 +49 G/G genotype is associated with reduced incidence of hepatitis B virus recurrence after liver transplantation among Chinese patients.

    AFFILIATION: Key Lab of Combined Multi-Organ Transplantation, Ministry of Public Health, Department of Hepatobiliary Surgery, the First Affiliated Hospital of Medical College, Zhejiang University, Hangzhou, China.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Liver Int

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Recipient cytotoxic T lymphocyte antigen-4 +49 G/G genotype is associated with reduced incidence of hepatitis B virus recurrence after liver transplantation among Chinese patients Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News